Scientists hunt for hidden immune clues in common lung diseases
NCT ID NCT06144476
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to better understand asthma and COPD by comparing immune markers in blood and airways of patients versus healthy volunteers. Researchers will analyze samples from 230 adults to identify distinct immune patterns linked to disease severity. The goal is to improve diagnosis and treatment of these common lung conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal distinct immune patterns that help doctors better diagnose and treat asthma and COPD in the future.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to gather knowledge, not test a new therapy, so there is no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AIRWAY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guy's & St Thomas' NHS Foundation Trust
RECRUITINGLondon, London, SE1 9RT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Can tracking severe asthma over time unlock better treatments?
- Breathing easy? new X-Ray method may spot COPD decline early
- Blood test may curb antibiotic overuse in COPD attacks
- Can pressurized breathing boost mucus clearance in lung disease?
- HIV and hidden health risks: a major study probes the link